These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 31424390)

  • 21. Apathy and APOE4 are associated with reduced BDNF levels in Alzheimer's disease.
    Alvarez A; Aleixandre M; Linares C; Masliah E; Moessler H
    J Alzheimers Dis; 2014; 42(4):1347-55. PubMed ID: 25024337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential impact of ApoE ε4 on cortical activation during famous face recognition in cognitively intact individuals and patients with amnestic mild cognitive impairment.
    Frank G; Hennig-Fast K; Klünemann HH; Schmitz G; Greenlee MW
    Alzheimer Dis Assoc Disord; 2011; 25(3):250-61. PubMed ID: 21192235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential Effects of APOE Genotypes on the Anterior and Posterior Subnetworks of Default Mode Network in Amnestic Mild Cognitive Impairment.
    Yuan B; Xie C; Shu H; Liao W; Wang Z; Liu D; Zhang Z
    J Alzheimers Dis; 2016 Oct; 54(4):1409-1423. PubMed ID: 27589521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. APOE ɛ4 constrains engagement of encoding-related compensatory networks in amnestic mild cognitive impairment.
    Prieto del Val L; Cantero JL; Atienza M
    Hippocampus; 2015 Sep; 25(9):993-1007. PubMed ID: 25616215
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Higher Peripheral TREM2 mRNA Levels Relate to Cognitive Deficits and Hippocampal Atrophy in Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
    Tan YJ; Ng ASL; Vipin A; Lim JKW; Chander RJ; Ji F; Qiu Y; Ting SKS; Hameed S; Lee TS; Zeng L; Kandiah N; Zhou J
    J Alzheimers Dis; 2017; 58(2):413-423. PubMed ID: 28453482
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative electroencephalography (qEEG), apolipoprotein A-I (APOA-I), and apolipoprotein epsilon 4 (APOE ɛ4) alleles for the diagnosis of mild cognitive impairment and Alzheimer's disease.
    Niu X; Wang Y; Zhang X; Wang Y; Shao W; Chen L; Yang Z; Peng D
    Neurol Sci; 2024 Feb; 45(2):547-556. PubMed ID: 37673807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical predictors of progression to Alzheimer disease in amnestic mild cognitive impairment.
    Fleisher AS; Sowell BB; Taylor C; Gamst AC; Petersen RC; Thal LJ;
    Neurology; 2007 May; 68(19):1588-95. PubMed ID: 17287448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of white matter hyperintensities (WMHs) and apolipoprotein E (APOE) genotypes on cognition in patients with amnestic mild cognitive impairment (aMCI).
    Yoon B; Shim YS; Cheong HK; Kim YD; Lee KO; Hong YJ; Oh YS; Na HR; Kim BC; Choi SH; Yang DW
    Arch Gerontol Geriatr; 2013; 57(3):292-7. PubMed ID: 23688406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of the C47T Polymorphism in SOD2 with Amnestic Mild Cognitive Impairment and Alzheimer's Disease in Carriers of the APOEε4 Allele.
    Gamarra D; Elcoroaristizabal X; Fernández-Martínez M; de Pancorbo MM
    Dis Markers; 2015; 2015():746329. PubMed ID: 26696693
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Butyrylcholinesterase K and Apolipoprotein E-ɛ4 Reduce the Age of Onset of Alzheimer's Disease, Accelerate Cognitive Decline, and Modulate Donepezil Response in Mild Cognitively Impaired Subjects.
    De Beaumont L; Pelleieux S; Lamarre-Théroux L; Dea D; Poirier J;
    J Alzheimers Dis; 2016 Oct; 54(3):913-922. PubMed ID: 27567841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human analogue of the morris water maze for testing subjects at risk of Alzheimer's disease.
    Laczó J; Andel R; Vyhnalek M; Vlcek K; Magerova H; Varjassyova A; Tolar M; Hort J
    Neurodegener Dis; 2010; 7(1-3):148-52. PubMed ID: 20197695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conversion from MCI to AD in patients with the APOE ε4 genotype: Prediction by plasma HCY and serum BDNF.
    Zheng L; Kong X; Cui Y; Wei Y; Zhang J; Wei W
    Neurosci Lett; 2016 Jul; 626():19-24. PubMed ID: 27180036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
    Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
    Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severity-Related Increase and Cognitive Correlates of Serum VEGF Levels in Alzheimer's Disease ApoE4 Carriers.
    Alvarez XA; Alvarez I; Aleixandre M; Linares C; Muresanu D; Winter S; Moessler H
    J Alzheimers Dis; 2018; 63(3):1003-1013. PubMed ID: 29710700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NK Cells are Activated in Amnestic Mild Cognitive Impairment but not in Mild Alzheimer's Disease Patients.
    Le Page A; Bourgade K; Lamoureux J; Frost E; Pawelec G; Larbi A; Witkowski JM; Dupuis G; Fülöp T
    J Alzheimers Dis; 2015; 46(1):93-107. PubMed ID: 25720398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
    Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
    EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the NIH Toolbox Odor Identification Test across normal cognition, amnestic mild cognitive impairment, and dementia due to Alzheimer's disease.
    Echevarria-Cooper SL; Ho EH; Gershon RC; Weintraub S; Kahnt T
    Alzheimers Dement; 2024 Jan; 20(1):288-300. PubMed ID: 37603693
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A single-dose pilot trial of intranasal rapid-acting insulin in apolipoprotein E4 carriers with mild-moderate Alzheimer's disease.
    Rosenbloom MH; Barclay TR; Pyle M; Owens BL; Cagan AB; Anderson CP; Frey WH; Hanson LR
    CNS Drugs; 2014 Dec; 28(12):1185-9. PubMed ID: 25373630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Family history and APOE4 risk for Alzheimer's disease impact the neural correlates of episodic memory by early midlife.
    Rajah MN; Wallace LMK; Ankudowich E; Yu EH; Swierkot A; Patel R; Chakravarty MM; Naumova D; Pruessner J; Joober R; Gauthier S; Pasvanis S
    Neuroimage Clin; 2017; 14():760-774. PubMed ID: 28413778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PKR Inhibition Rescues Memory Deficit and ATF4 Overexpression in ApoE ε4 Human Replacement Mice.
    Segev Y; Barrera I; Ounallah-Saad H; Wibrand K; Sporild I; Livne A; Rosenberg T; David O; Mints M; Bramham CR; Rosenblum K
    J Neurosci; 2015 Sep; 35(38):12986-93. PubMed ID: 26400930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.